Carlisle Companies has reshaped itself into a focused North American building envelope pure play, and the Q2 FY2026 results out in late July 2026 show the model working as designed. Consolidated revenue of $1,570.3M rose 8.3% against the prior year period. Diluted earnings per share from continuing operations of $6.36 grew 8.4%. The prior year comparison base was lower. The quarterly adjusted EBITDA margin of 26.2% compressed 70 basis points. Petrochemical raw material and freight costs spiked on Middle East conflict, illustrating that the margin profile responds to commodity shocks. Operating volume trends remain favorable even through the input pressure, and the underlying franchise absorbs the shock without a structural margin reset.
Carlisle Construction Materials (CCM) and Carlisle Weatherproofing Technologies (CWT) are now the only two reportable segments following the prior segment pruning toward Vision 2030. CCM revenue grew 7.8% in Q2. CWT revenue grew 9.9% and CWT adjusted EBITDA margin expanded 380 basis points sequentially from the prior quarter. The two segment concentration simplifies the operating narrative, and the segment disclosures give investors a direct read on each franchise rather than forcing aggregation across unrelated businesses. Buybacks of $250.0M in the quarter pushed diluted share count lower by 6.8% year over year. Full year repurchase guidance has been lifted to $1.2B. The capital allocation lever adds a separate support layer on top of operating execution.
Pricing realization lags cost inflation by one to two quarters historically, so the book of price actions taken in April and July, with a third in August, frames the back half of 2026 as the proof point. Re-roofing demand has stayed resilient, with above market volume growth at both segments. The setup favors Carlisle through the cycle, though the answer hinges on whether margin recovers faster than consensus models. Investors looking for a focused industrial building envelope name with a credible margin recovery story, a disciplined capital allocation framework, and a balanced risk reward at current multiples should find Carlisle a reasonable addition at the current reference price near $352. The Q3 2026 print provides the next major catalyst. The Q4 print should validate whether the full year margin recovery holds the consolidated adjusted EBITDA margin near the 26% level.